Literature DB >> 20445108

Macular pigment optical density in central serous chorioretinopathy.

Yuzuru Sasamoto1, Fumi Gomi, Miki Sawa, Motokazu Tsujikawa, Toshimitsu Hamasaki.   

Abstract

PURPOSE: To evaluate macular pigment optical density (MPOD) in patients with central serous chorioretinopathy (CSC) and in normal subjects.
METHODS: MPOD was measured by autofluorescence spectrometry by using a two-wavelength
METHOD: Central retinal thickness (CRT) was measured with optical coherence tomography. Statistical analyses were performed to determine factors associated with MPOD.
RESULTS: Ninety-four eyes of 94 normal control subjects, 123 eyes of 70 patients with chronic CSC, and 74 eyes of 41 patients with acute CSC were included. The mean MPOD was 0.548 density unit (DU; 95% confidence interval [CI]; 0.516-0.580) in the control group. Stepwise regression analysis of the control group showed that CRT was associated positively with MPOD (P = 0.0079). The mean MPOD was 0.386 DU (95% CI, 0.352-0.420) in the eyes with chronic CSC, 0.443 DU (95% CI, 0.401-0.484) in fellow eyes with chronic CSC, 0.542 DU (95% CI, 0.493-0.590) in affected eyes with acute CSC, and 0.528 DU (95% CI, 0.475-0.582) in fellow eyes with acute CSC. Stepwise regression analysis showed a significant association between eyes with a lower MPOD and affected eyes with chronic CSC (P = 0.0126) and fellow eyes with chronic CSC (P = 0.0023) and a thinner central retina (P = 0.0016).
CONCLUSIONS: MPOD may decrease in eyes with chronic CSC and in the fellow eyes. Low MPOD may indicate a risk of chronic CSC, and a decrease in MPOD may be accelerated by thinning of the central retina.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20445108     DOI: 10.1167/iovs.09-4881

Source DB:  PubMed          Journal:  Invest Ophthalmol Vis Sci        ISSN: 0146-0404            Impact factor:   4.799


  8 in total

1.  Effect of 1-year lutein supplementation on macular pigment optical density and visual function.

Authors:  Yuzuru Sasamoto; Fumi Gomi; Miki Sawa; Motokazu Tsujikawa; Kohji Nishida
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2011-08-18       Impact factor: 3.117

2.  Inverse relationship between macular pigment optical density and axial length in Chinese subjects with myopia.

Authors:  Nianting Tong; Wei Zhang; Zhenzhen Zhang; Yuanyuan Gong; Billy Wooten; Xingwei Wu
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2012-12-08       Impact factor: 3.117

3.  Comparison of macular pigment in three types of macular telangiectasia.

Authors:  Miki Sawa; Fumi Gomi; Chikako Ueno; Mihoko Suzuki; Kohji Nishida
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2012-07-12       Impact factor: 3.117

4.  FUNDUS AUTOFLUORESCENCE LIFETIMES AND CENTRAL SEROUS CHORIORETINOPATHY.

Authors:  Chantal Dysli; Lieselotte Berger; Sebastian Wolf; Martin S Zinkernagel
Journal:  Retina       Date:  2017-11       Impact factor: 4.256

5.  Macular pigment density changes in central serous chorioretinopathy.

Authors:  Ruxandra Tudosescu; Cristina Mihaela Alexandrescu; Sinziana Luminita Istrate; Alexandra Vrapciu; Radu Constantin Ciuluvica; Liliana Mary Voinea
Journal:  Rom J Ophthalmol       Date:  2018 Jul-Sep

6.  Repeatability of the macular pigment spatial profile: A comparison of objective versus subjective classification.

Authors:  Irene Ctori; Omar A Mahroo; Katie M Williams; Christopher J Hammond; Byki Huntjens
Journal:  Acta Ophthalmol       Date:  2018-08-29       Impact factor: 3.761

7.  Macular pigment optical density in central serous chorioretinopathy.

Authors:  Burcu Polat Gultekin; Esra Sahli
Journal:  Ther Adv Ophthalmol       Date:  2021-03-03

8.  Investigation of Serum and Macular Carotenoids in Central Serous Chorioretinopathy.

Authors:  Yuying Ji; Yuhong Gan; Yongyue Su; Yining Zhang; Miaoling Li; Lan Mi; Chengguo Zuo; Feng Wen
Journal:  Front Med (Lausanne)       Date:  2022-04-01
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.